Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

New ImmunoCAP Bee Venom Components

Products are for professional/laboratory use only.

Discover the new ImmunoCAP bee venom components

  • Patients with primary bee sensitization may test negative for Api m 1 but positive for other bee venom components.
  • Api m 10 can be absent or/underrepresented in VIT extracts – VIT of patients sensitized to this component may be less efficient.
  • Adding venom components rApi m 2, rApi m 5 and rApi m 10 to your test panel improves diagnostic specificity and supports more well-founded decisions for VIT.
  • Successful venom immunotherapy (VIT) is more likely when treatment selection is based on genuine sensitization to bee and/or wasp venom.

View Literature Review

Download Flyer >

View Case Studies

Download Now >

ImmunoCAP Allergen Components help you resolve double positivity

Distinguish between true co-sensitization to bee and wasp, and CCD-dependent cross reactivity

  • Honey bee: rApi m 1, rApi m 2, rApi m 5 and rApi m 10
  • Common/paper wasp: rVes v 1, rVes v 5, rPol d 5

Help match venom immunotherapy to the patient’s sensitization profile

A broad toolbox of ImmunoCAP  allergen components

Over 100 allergen components that can help you:

  • Assess risk of systemic reactions in patients with food allergy
  • Explain symptoms due to cross-reactivity
  • Identify the appropriate immunotherapy for the individual patient

Find out more

Download Brochure >

View Pocket Card

Download Now >

Contact us for a quote

Contact Us Now >

References

  • Biló B et al & EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of Hymenoptera venom allergy. Allergy 2005; 60: 1339–1349.
  • Bonifazi F et al & EAACI Interest Group on Insect Venom Hypersensitivity. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005; 60: 1459–
  • Müller U. et al, Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m 1 and Ves v 5. Allergy 2009; 64: 543–548.
  • Spillner E. et al., Hymenoptera allergens: from venom to ”venome”. Frontiers in immunology 2014; 5: 1-7.
  • Mittermann I et al. Recombinant allergen-based IgE testing to distinguish bee and wasp allergy. J Allergy Clin Immunol 2010; 125: 1300–1307.
  • Blank S. et al., Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts. Allergy 2011; 66: 1322-1329
  • Grunwald T. et al., Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3). J Allergy Clin Immunol 2006; 117: 848-54.
  • Köhler J et al. Component resolution reveals additional major

View detailed References

Download Now >



Request a Quote

Request Quote

Recent Posts

2026 Thermo Fisher Product Catalogue now available

We are pleased to launch the 2026 edition of the Thermo Fisher Phadia product catalogue for ImmunoCAP and EliA. (more…)

Read full article

IBL International – Proinsulin Intact ELISA.*

Unlock the future of diabetes detection with Proinsulin Intact ELISA for early and accurate diagnosis. Proinsulin, primarily produced in pancreatic β-cells, undergoes processing into insulin and…

Read full article

Clinical Utility of ImmunoCAP Tryptase

ImmunoCAP Tryptase is a well-known clinical marker in explaining severe reactions cause by insect venoms, drugs, or in systemic mastocytosis. (more…)

Read full article